Skip to main content
Top
Published in: Supportive Care in Cancer 10/2017

01-10-2017 | Original Article

Integration of oncology and palliative care: setting a benchmark

Authors: P. Vayne-Bossert, E. Richard, P. Good, K. Sullivan, J.R. Hardy

Published in: Supportive Care in Cancer | Issue 10/2017

Login to get access

Abstract

Background

Integration of oncology and palliative care (PC) should be the standard model of care for patients with advanced cancer. An expert panel developed criteria that constitute integration. This study determined whether the PC service within this Health Service, which is considered to be fully “integrated”, could be benchmarked against these criteria.

Methods

A survey was undertaken to determine the perceived level of integration of oncology and palliative care by all health care professionals (HCPs) within our cancer centre. An objective determination of integration was obtained from chart reviews of deceased patients. Integration was defined as >70% of all respondents answered “agree” or “strongly agree” to each indicator and >70% of patient charts supported each criteria.

Results

Thirty-four HCPs participated in the survey (response rate 69%). Over 90% were aware of the outpatient PC clinic, interdisciplinary and consultation team, PC senior leadership, and the acceptance of concurrent anticancer therapy. None of the other criteria met the 70% agreement mark but many respondents lacked the necessary knowledge to respond.
The chart review included 67 patients, 92% of whom were seen by the PC team prior to death. The median time from referral to death was 103 days (range 0–1347). The level of agreement across all criteria was below our predefined definition of integration.

Conclusion

The integration criteria relating to service delivery are medically focused and do not lend themselves to interdisciplinary review. The objective criteria can be audited and serve both as a benchmark and a basis for improvement activities.
Literature
1.
go back to reference Yennurajalingam S, Urbauer DL, Casper KL et al (2011) Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manag 41:49–56CrossRef Yennurajalingam S, Urbauer DL, Casper KL et al (2011) Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manag 41:49–56CrossRef
2.
go back to reference Hui D, Kim YJ, Park JC et al (2015) Integration of oncology and palliative care: a systematic review. Oncologist 20:77–83CrossRefPubMed Hui D, Kim YJ, Park JC et al (2015) Integration of oncology and palliative care: a systematic review. Oncologist 20:77–83CrossRefPubMed
3.
go back to reference Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed
4.
go back to reference Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730CrossRefPubMed Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730CrossRefPubMed
5.
go back to reference (ESMO) ESfMO (2003). Designated centres of integrated oncology and palliative care. In (ESMO) ESfMO (2003). Designated centres of integrated oncology and palliative care. In
6.
go back to reference Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887CrossRefPubMed Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887CrossRefPubMed
7.
go back to reference Ferrell B, Temel JS, Termin S et al (2016) Integration of Palliative Care Into STandard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology Epub Ferrell B, Temel JS, Termin S et al (2016) Integration of Palliative Care Into STandard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology Epub
8.
go back to reference Rhee KJ, Donabedian A, Burney RE (1987) Assessing the quality of care in a hospital emergency unit: a framework and its application. QRB Qual Rev Bull 13:4–16CrossRefPubMed Rhee KJ, Donabedian A, Burney RE (1987) Assessing the quality of care in a hospital emergency unit: a framework and its application. QRB Qual Rev Bull 13:4–16CrossRefPubMed
9.
go back to reference Hui D, Bansal S, Strasser F et al (2015) Indicators of integration of oncology and palliative care programs: an international consensus. Ann Oncol 26:1953–1959CrossRefPubMedPubMedCentral Hui D, Bansal S, Strasser F et al (2015) Indicators of integration of oncology and palliative care programs: an international consensus. Ann Oncol 26:1953–1959CrossRefPubMedPubMedCentral
10.
go back to reference Hui D, Bruera E (2015) Models of integration of oncology and palliative care. Ann Palliat Med 4:89–98PubMed Hui D, Bruera E (2015) Models of integration of oncology and palliative care. Ann Palliat Med 4:89–98PubMed
Metadata
Title
Integration of oncology and palliative care: setting a benchmark
Authors
P. Vayne-Bossert
E. Richard
P. Good
K. Sullivan
J.R. Hardy
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3736-2

Other articles of this Issue 10/2017

Supportive Care in Cancer 10/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine